Skip to content
10-Q

Quarterly Report

FATE THERAPEUTICS, INC. FATE

0001193125-25-279096

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 6, 2025 115.35M sh
Shares Diluted Q3 2025 · Sep 30, 2025 119M sh
Shares Diluted Q3 2025 · Sep 30, 2025 118.64M sh
Shares Diluted Q3 2025 · Sep 30, 2024 117.77M sh
Shares Diluted Q3 2025 · Sep 30, 2024 112.31M sh
Capex Q3 2025 · Sep 30, 2025 $4.76M
Capex Q3 2025 · Sep 30, 2024 $632K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$82.77M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$95.08M
Short Term Investments Q3 2025 · Sep 30, 2025 $174.8M
Short Term Investments Q3 2025 · Dec 31, 2024 $243.01M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $40.62M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $36.06M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $37.91M
Stockholders Equity Q3 2025 · Sep 30, 2025 $234.07M
Stockholders Equity Q3 2025 · Jun 30, 2025 $261.36M
Stockholders Equity Q3 2025 · Mar 31, 2025 $288.41M
Stockholders Equity Q3 2025 · Dec 31, 2024 $318.73M
Stockholders Equity Q3 2025 · Sep 30, 2024 $362.33M
Stockholders Equity Q3 2025 · Jun 30, 2024 $396.98M
Stockholders Equity Q3 2025 · Mar 31, 2024 $426.12M
Stockholders Equity Q3 2025 · Dec 31, 2023 $368.42M
Current Liabilities Q3 2025 · Sep 30, 2025 $28.11M
Current Liabilities Q3 2025 · Dec 31, 2024 $38.52M
Current Assets Q3 2025 · Sep 30, 2025 $221.25M
Current Assets Q3 2025 · Dec 31, 2024 $291.91M
Total Assets Q3 2025 · Sep 30, 2025 $343.67M
Total Assets Q3 2025 · Dec 31, 2024 $440.69M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.27
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.88
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.40
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.19
Eps Basic Q3 2025 · Sep 30, 2025 −$0.27
Eps Basic Q3 2025 · Sep 30, 2025 −$0.88
Eps Basic Q3 2025 · Sep 30, 2024 −$0.40
Eps Basic Q3 2025 · Sep 30, 2024 −$1.19
Sga Expense Q3 2025 · Sep 30, 2025 $10.64M
Sga Expense Q3 2025 · Sep 30, 2025 $35.86M
Sga Expense Q3 2025 · Sep 30, 2024 $20.8M
Sga Expense Q3 2025 · Sep 30, 2024 $58.91M
Rd Expense Q3 2025 · Sep 30, 2025 $25.84M
Rd Expense Q3 2025 · Sep 30, 2025 $82.4M
Rd Expense Q3 2025 · Sep 30, 2024 $34.65M
Rd Expense Q3 2025 · Sep 30, 2024 $101.39M
Net Income Q3 2025 · Sep 30, 2025 −$32.25M
Net Income Q3 2025 · Sep 30, 2025 −$103.94M
Net Income Q3 2025 · Jun 30, 2025 −$34.07M
Net Income Q3 2025 · Mar 31, 2025 −$37.62M
Net Income Q3 2025 · Sep 30, 2024 −$47.68M
Net Income Q3 2025 · Sep 30, 2024 −$134.11M
Net Income Q3 2025 · Jun 30, 2024 −$38.43M
Net Income Q3 2025 · Mar 31, 2024 −$48M
Operating Income Q3 2025 · Sep 30, 2025 −$34.74M
Operating Income Q3 2025 · Sep 30, 2025 −$112.98M
Operating Income Q3 2025 · Sep 30, 2024 −$52.38M
Operating Income Q3 2025 · Sep 30, 2024 −$148.53M
Revenue Q3 2025 · Sep 30, 2025 $1.74M
Revenue Q3 2025 · Sep 30, 2025 $5.28M
Revenue Q3 2025 · Sep 30, 2024 $3.07M
Revenue Q3 2025 · Sep 30, 2024 $11.77M